Vonderheide, Robert H.

Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs

Mastio, J., Condamine, T., Dominguez, G., Kossenkov, A. V., Donthireddy, L., Veglia, F., Lin, C., Wang, F., Fu, S., Zhou, J., et al. (2019) · Journal of Experimental Medicine

Immune cells in cancerImmunotherapy and Immune Responses

Cited by 115

Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting

Bear, A. S., Blanchard, T., Cesare, J., Ford, M. J., Richman, L. P., Xu, C., Baroja, M. L., McCuaig, S., Costeas, C., Gabunia, K., et al. (2021) · Nature Communications

Immunotherapy and Immune Responsesvaccines and immunoinformatics approaches

Cited by 113

CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice

Zhang, Y., Yan, W., Mathew, E., Bednar, F., Wan, S., Collins, M. A., Evans, R. A., Welling, T. H., Vonderheide, R. H., & di Magliano, M. P. (2014) · Cancer Immunology Research

Pancreatic and Hepatic Oncology ResearchT-cell and B-cell Immunology

Cited by 102

Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiency

Calcedo, R., Somanathan, S., Qin, Q., Betts, M. R., Rech, A. J., Vonderheide, R. H., Mueller, C., Flotte, T. R., & Wilson, J. M. (2017) · Proceedings of the National Academy of Sciences

Virus-based gene therapy researchImmunotherapy and Immune Responses

Cited by 79

Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and Immunotherapy

Janowitz, T., Kleeman, S., & Vonderheide, R. H. (2021) · The Oncologist

Cancer Immunotherapy and BiomarkersNausea and vomiting management

Cited by 42